Experiments in three therapeutic cancer vaccine mouse models, conducted by investigators at the Vaccine Branch of the National Cancer Institute in Bethesda, Maryland, support the conclusion that ...

Angiotensin receptor blockers exhibited potential neuroprotective properties for reducing Parkinson disease (PD) risk in patients with newly diagnosed hypertension. A statistically significant ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. While several trials of angiotensin receptor blockers in ...

Early data from the ADAPT JR trial suggest efgartigimod may benefit adolescents with generalized myasthenia gravis, a rare ...

A research team from the Department of Bioscience, Faculty of Life Sciences, Okayama University of Science, has made a ...

Sparsentan therapy was associated with sustained decline in proteinuria and lower likelihood of progression to kidney failure ...

Type 1 diabetes with CKD is understudied with no advancement of therapy options since the 1990s. The FINE-ONE phase 3 trial addresses a high, unmet need for treatments.

Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control ...